Sittner & Nelson »

Crispr Therapeutics shares owned by Sittner & Nelson

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sittner & Nelson from 13F filings

Historical chart of Sittner & Nelson investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Sittner & Nelson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Sittner & Nelson

Quarter filed Position value Share count Share price at filing
2024-09-30 $176k 3.7k 46.98
2024-06-30 $192k 3.5k 54.01
2024-03-31 $262k 3.8k 68.16
2023-09-30 $167k 3.7k 45.39
2023-06-30 $199k 3.5k 56.14
2023-03-31 $160k 3.5k 45.23
2022-12-31 $139k 3.4k 40.65
2022-09-30 $224k 3.4k 65.36
2022-06-30 $208k 3.4k 60.69
2022-03-31 $215k 3.4k 62.74
2021-12-31 $207k 2.7k 75.91
2021-09-30 $282k 2.5k 112.04
2021-06-30 $264k 1.6k 161.96
2021-03-31 $146k 1.2k 121.67